Hap Trading, LLC Nektar Therapeutics Put Options Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$3.17 - $6.17 $55,475 - $107,975
-17,500 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$4.16 - $13.72 $24,544 - $80,948
5,900 Added 50.86%
17,500 $74,000
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $12,996 - $22,092
1,200 Added 11.54%
11,600 $37,000
Q4 2019

Feb 11, 2020
BUY
$15.87 - $23.12 $165,048 - $240,448
10,400 New
10,400 $62,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $178M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email